Arrhythmogenic right venticular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy with a very low penetrance affecting the right ventricle (RV) and presenting palpitation and syncope due to ventricular tachycardia (VT) originating from RV. The VT can degenerate into ventricular fibrillation and sudden cardiac death. The genetic background of ARVD/C has recently been found to be heterogeneous, mainly resulting from cell adhesion abnormalities due to mutations in five different genes encoding members of the desmosome complex. In Asian countries, however, the genetic aspect of the disease has not been fully studied, although the clinical features of Asian ARVD/C patients are different from those in Western countries in the penetrance of phenotypes, relation to Brugada syndrome and link to RV outflow tract ventricular tachycardia. It is of urgent need to have a registry of Asian ARVD/C patients and to conduct a more detailed genetic survey on the candidate genes, including desomosomal ones. (J Arrhythmia 2008; 24: 195-199) 
Introduction
Arrhythmogenic right venticular dysplasia/cardiomyopathy (or ARVD/C) is an inherited cardiomyopathy with a very low penetrance affecting the right ventricle (RV) and presenting palpitation and syncope due to ventricular tachycardia (VT) originating from RV. [1] [2] [3] The VT can degenerate into ventricular fibrillation and sudden cardiac death (SCD). The disease is three times more prevalent in men than in women. An Italian study 4) gives an estimated prevalence for ARVD/C ranging from 1 in 2,000 to 1 in 5,000. In contrast, it has been reported to be only 1 in 160,000 in Japan. 5) Although detailed epidemiology and prevalence of ARVD/C remains unknown in Asian countries, there is a definite ethnic difference in the occurrence of the disease. Sudden death can be the first clinical manifestation of the disease in more than 50% of patients with ARVC. 6) This indicates that fatal ventricular arrhythmias can cause SCD even in the concealed stage with subtle RV structural change. 7) Although fatty and/or fibro-fatty replacement of the RV myocardium is the pathological hallmark of the disease, 8) RV biopsy is of limited use for patients in the stage with minimally involvement and is too invasive as a technique for diagnosis. In addition, some of the other criteria suggested by task forces [8] [9] [10] cannot be applied to patients in earlier stages of the disease. Therefore, another approach is needed for its diagnosis. More recently, vigorous studies in Western countries unveiled the molecular and genetic backgrounds of the disease: 11 chromosomal loci and 7 responsible genes have been reported ( Table 1) , offering another diagnostic method.
Desmosomal genes and ARVD/C
The studies screening the genetic background have been conducted because familial cases accounted for 30% to 50% in Europe, 8, 11) showing an autosomal dominant trait with incomplete penetrance. As listed in Table 1 , ARVD/C is now known to be very heterogenous, mainly resulting from cell adhesion abnormalities since five identified responsible genes are all coding members of the desmosome complex (Figure) . It is a cell adhesion apparatus which binds neighboring cells tightly and consists of at least 5 associated proteins. The discovery of desmosomal gene mutations as a genetic variant responsible for ARVD/C started from the clinical description of Naxos disease (Table 1) in 1986 by Greek physicians, Protonotarios and colleagues. 12) They reported that Naxos disease is inherited in an autosomal recessive manner, specific to the Naxos island of Aegean Sea and characterized by (1) ARVD/C, (2) palmoplantar keratoderma and (3) wooly hair. By a means of linkage analysis in typical families, a mutation in the gene encoding plakoglobin (a member of desmosome complex proteins: JUP) was identified to cause the disease 14 years after it was first described. 13) Thereafter many researchers began to speculate that mutations in gene members coding the desmosomal complex might be associated with the disease. In other words, the discovery of plakoglobin triggered the hypothesis that the disorder is linked to abnormalities in cell adhesion molecules, i.e., desmosomal proteins. Within several years, mutations in 4 other desmosomal genes, desmoplakin (DSP: ARVC8), plakophillin (PKP2: ARVC9), desmoglein (DSG2: ARVC10) and desmocollin (DSC2: ARVC11), have been reported to be responsible for ARVD/C (Table 1 & Figure) .
Genetic background of Asian ARVD/C patients remains unclear
In Western countries, PKP2 mutations have been shown to be most prevalent in patients. Various types of PKP2 mutations were identified in 27% of 120, 14) 43% of 58 15) and in 43% of 56 patients. 16) In contrast, the genetic background and precise distribution of desmosomal gene mutations are unknown in Asian countries. More recently, we have started to collect genomic DNA from the registry of Japanese ARVD/C patients and published case reports on novel PKP2 mutations. 17, 18) Our results on a limited number of ARVD/C probands revealed that PKP2 mutations are also common in Japan (6 of 17 probands, 35%). 19) As for a reason why Western researchers could so rapidly conduct detailed genetic screening on their ARVD/C patients or why we were delayed, it was of clinical importance that they had already full sets of genomic DNA collections, because was well understood that ARVD/C is a hereditary disease. Our clinical impression on ARVD/C, however, somewhat differs from theirs: the occurrence of the disease is sporadic and familial cases are rather rare. Regarding a case of young boy in whom we could identify a novel PKP2 mutation, Q378X, extensive genetic tests in his family members revealed that his parents were free of mutation, indicating that the mutation was de novo and this was really a sporadic case. 18) However, the precise prevalence of de novo cases remains unknown because of lack of data available for genomic DNA of patients. Based on autopsy data of 38 Korean patients with SCD, Cho and his colleagues 20) demonstrated that ARVD/C was the most common cause of SCD (42%) and most of victims were found dead in bed or during ordinary daily activity. These properties differ from those reported by European researchers. Their patients' SCD is reportedly associated with strenuous exercise. Therefore, it is now time to start a global registry of Asian ARVD/C patients and to conduct a more extensive genetic survey on the candidate genes, including desmosomal ones. The genetic profile of our ARVD/C cases may reflect ethnic differences from those reported in Western countries in terms of responsible genes and their penetrance.
Other unresolved issues in the ARVD/C study One of the major remaining questions is why the disease first affects the RV. As we now know that ARVD/C is very heterogeneous in terms of genetic causes, there may be gene-specific variations in phenotype. Some types may develop fatal arrhythmia before structural changes in RV and others may not. Indeed, PKP2 mutations appeared to be more arrhythmogenic from an earlier stage of the disease. These differences in clinical features may partially result from PKP2 linkage with other key molecules for cell-to-cell connection. 21, 22) In order to diagnose possible ARVD/C cases, task force or modified diagnostic criteria have been widely used ( Table 2) . [8] [9] [10] The diagnosis of ARVD/ C can be fulfilled by the presence of 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria from different groups. For example if your patient has a confirmed family history and severe RV dilatation with reduced RV ejection fraction, he is most probably affected with ARVD/C. However, the current criteria are not applicable to patients with earlier stages of disease who have no family history. Nevertheless, fatal arrhythmias can occur from the very beginning of disease development. Therefore, the genetic testing focusing on desmosomal genes offers a strong diagnostic tool, particularly for patients in an early stage of the disease and family members with genetically confirmed ARVD/C probands.
As another unanswered issue, some ARVD/C cases overlap clinical features with nocturnal sudden death (or Brugada syndrome) and VT originating from the RV outflow. [23] [24] [25] [26] [27] [28] [29] The former syndrome may not only be primarily electrical but may involve structural disease, especially in the RV outflow area. Regarding the relation between ARVD/C and RV outflow-origin VT, we identified a missense muta-tion of desmoplakin (DSP) in an 18-year-old female who complained of recurrent presyncope due to nonsustained VT from the RV outflow tract but did not satisfy the criteria (no family history, no morphological abnormality). Catheter ablation was partially successful to suppress her VT, and we are carefully following the patient to see whether she develops typical phenotypes of ARVD/C under the concept that RV outflow tract VT can be a very early stage of forme fruste ARVD/C. 29) In conclusion, both clinical and genetic aspects of ARVD/C are not yet fully studied in Asians. Although the disease is uncommon, it is feasible to find a breakthrough for the etiology of other overlapping diseases such as RV outflow tract VT, Brugada syndrome or even common VT. Finally, let us make a remark again that recent swift progress on ARVD/C study was mostly triggered by the discovery of genes responsible for the Naxos disease. It reminds us of Dr. William Harvey's famous epigram: the study of uncommon illness often allows us 
ECG repolarization abnormalities
Minor: Inverted T waves in right precordial leads (V2 and V3) in people >12 years of age and in absence of right bundle branch block.
Arrhythmias
Minor: Sustained or nonsustained left bundle branch block-type ventricular tachycardia documented on ECG or Holter monitoring or during exercise testing. Frequent ventricular extrasystoles (>1000=24 h on Holter monitoring). 5. Global or regional dysfunction and structural alterations Ã Major: Severe dilatation and reduction of RV ejection fraction with no or mild LV involvement.
Localized RV aneurysms (akinetic or dyskinetic areas with diastolic bulgings). Severe segmental dilatation of RV. Minor: Mild global RV dilatation or ejection fraction reduction with normal LV. Mild segmental dilatation of RV. Regional RV hypokinesia.
Tissue characteristics of walls
Major: Fibrofatty replacement of myocardium on endomyocardial biopsy. Ã Detected by echocardiography, angiography, magnetic resonance imaging, or radionuclide scintigraphy. (ref. #9) to better understand the mechanisms of common disease. It is now time to start an extensive registry of Asian ARVD/C patients.
